ABVC BioPharma, Inc.
ABVC
$0.742
-$0.1725-18.86%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 208.20K | 200.00K | 106.40K | 139.50K | 568.60K |
| Total Receivables | 1.22M | 1.27M | 899.90K | 759.60K | 1.16M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 91.30K | 100.80K | 159.60K | 101.10K | 143.10K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 632.50K | 618.50K | 628.50K | 656.60K | 620.90K |
| Total Current Assets | 2.15M | 2.19M | 1.79M | 1.66M | 2.49M |
|
|
|||||
| Total Current Assets | 2.15M | 2.19M | 1.79M | 1.66M | 2.49M |
| Net Property, Plant & Equipment | 8.44M | 8.54M | 8.66M | 8.78M | 8.85M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.54M | 1.53M | 1.53M | 1.53M | 2.57M |
| Total Assets | 14.46M | 14.63M | 14.46M | 14.49M | 16.59M |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 3.18M | 3.31M | 3.13M | 3.26M | 3.56M |
| Short-term Debt | 1.11M | 1.03M | 1.01M | 919.00K | 1.33M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.49M | 1.48M | 1.38M | 1.12M | 392.70K |
| Total Finance Division Other Current Liabilities | 532.10K | 739.20K | 1.12M | 630.70K | 79.50K |
| Total Other Current Liabilities | 532.10K | 739.20K | 1.12M | 630.70K | 79.50K |
| Total Current Liabilities | 6.32M | 6.55M | 6.63M | 5.93M | 5.36M |
|
|
|||||
| Total Current Liabilities | 6.32M | 6.55M | 6.63M | 5.93M | 5.36M |
| Long-Term Debt | -- | -- | -- | -- | 1.65M |
| Short-term Debt | 1.11M | 1.03M | 1.01M | 919.00K | 1.33M |
| Capital Leases | 142.20K | 228.80K | 318.20K | 407.50K | 507.20K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 25.70K | 27.70K | 21.70K | 21.70K | 5.70K |
| Total Liabilities | 6.48M | 6.81M | 6.97M | 6.36M | 7.53M |
|
|
|||||
| Common Stock & APIC | 87.32M | 87.09M | 86.04M | 82.64M | 80.67M |
| Retained Earnings | -70.55M | -70.37M | -69.35M | -65.42M | -62.31M |
| Treasury Stock & Other | -8.41M | -8.44M | -8.89M | -8.84M | -9.26M |
| Total Common Equity | 8.36M | 8.29M | 7.79M | 8.39M | 9.10M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 8.36M | 8.29M | 7.79M | 8.39M | 9.10M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -379.10K | -465.20K | -305.10K | -257.10K | -38.30K |
| Total Equity | 7.98M | 7.83M | 7.49M | 8.13M | 9.06M |
|
|
|||||
